Moscow Scient. Res. Institute of Oncology n.a P.A. Hertzen

Moscow 125284

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Carcinoma, Transitional Cell

Studies at this site

• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed